Cancer · 1988 · 76 citations · 18 references
MedicineOncologyPathologyClinical BiochemistryCytopathologyMolecular PathologyLung CancerPleural DiseasePleural MalignanciesTumor AntigensTumor MarkersAdenosine Deaminase TestingMalignant Effusion DetectionMalignant Pleural EffusionPleural Effusion CytologyPleural Effusion EvaluationPleural Effusion In MalignancyPleural Tumor BiomarkersPrognostic Tumor Markers
In order to discriminate between malignant and benign effusions, the values of carcinoembryonic antigen (CEA), ferritin, beta2-microglobulin (BMG), acid-soluble glycoprotein (ASP), tissue polypeptide antigen (TPA), adenosine deaminase (ADA), and immunosuppressive acidic protein (IAP) were measured in the pleural fluid of 54 patients with lung cancer, 20 with malignancies other than lung cancer, 18 with tuberculous pleurisy, and 22 with benign diseases other than tuberculosis. CEA levels in malignant effusions were significantly higher than those in benign effusions. At a cutoff level of 5 ng/ml, 68% of the patients with lung cancer and 44% of the patients with other malignancies showed elevated pleural fluid CEA levels. In 13 lung cancer cases with negative pleural fluid cytology, nine cases had elevated pleural fluid CEA levels. The mean pleural fluid BMG level of patients with benign diseases was significantly higher than that of patients with malignant diseases, but there was a marked overlap between those with malignant and benign diseases. No significant differences were found in the pleural fluid ferritin, ASP, TPA, and IAP levels between malignant and benign conditions. ASP and IAP pleural fluid levels showed significant correlations with the pleural fluid C-reactive protein (CRP) concentrations suggesting that they also reflect inflammatory activity. The mean ADA activity in tuberculous effusion was significantly higher than that resulting from other causes of pleural effusion.
18
Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis.
Martina Piras, C Gakis, Mario Budroni et al. · BMJ · 1978 · 264 citations · Full text
Edmund C. Leuallen, David Carr · New England Journal of Medicine · 1955 · 183 citations
β2-Microglobulin levels in cancerous and other disease states
J. Shuster, Phil Gold, M. D. Poulik · Clinica Chimica Acta · 1976 · 177 citations
Medicine, Biochemistry, Oncology +6
JOANNE T. HAZARD, James W. Drysdale · Nature · 1977 · 161 citations